Dapsone-associated Methemoglobinemia in a Patient with Slow NAT2*5B Haplotype and Impaired Cytochrome B5 Reductase Activity

Overview

Journal J Clin Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 2011 Mar 23

PMID 21422237

Citations 3

Authors

Mahmoud Abouraya

James C Sacco

Kristie Hayes

Sajeve Thomas

Craig S Kitchens

Lauren A Trepanier

Affiliations

Soon will be listed here.

Citing Articles

Cutaneous Lupus Erythematosus: Review and Considerations for Older Populations.

Heinly B, Allenzara A, Helm M, Foulke G Drugs Aging. 2023; 41(1):31-43.

PMID: 37991658 DOI: 10.1007/s40266-023-01079-5.

Case Study 10: A Case to Investigate Acetyl Transferase Kinetics.

Dumouchel J, Kramlinger V Methods Mol Biol. 2021; 2342:781-808.

PMID: 34272717 DOI: 10.1007/978-1-0716-1554-6_29.

Immunogenicity of trimethoprim/sulfamethoxazole in a macaque model of HIV infection.

Wong Y, Rakasz E, Gasper D, Friedrich T, Trepanier L Toxicology. 2016; 368-369:10-18.

PMID: 27565715 PMC: 5069186. DOI: 10.1016/j.tox.2016.08.010.

References

Ganesan S, Tekwani B, Sahu R, Tripathi L, Walker L . Cytochrome P(450)-dependent toxic effects of primaquine on human erythrocytes. Toxicol Appl Pharmacol. 2009; 241(1):14-22. DOI: 10.1016/j.taap.2009.07.012. View

Mandrell B, McCormick J . Dapsone-induced methemoglobinemia in pediatric oncology patients: case examples. J Pediatr Oncol Nurs. 2001; 18(5):224-8. DOI: 10.1053/jpon.2001.26876. View

Dunford L, Roy D, Hahn T, Padmanabhan S, Segal B, Almyroudis N . Dapsone-induced methemoglobinemia after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2006; 12(2):241-2. DOI: 10.1016/j.bbmt.2005.10.008. View

Kurian J, Longlais B, Trepanier L . Discovery and characterization of a cytochrome b5 variant in humans with impaired hydroxylamine reduction capacity. Pharmacogenet Genomics. 2007; 17(8):597-603. DOI: 10.1097/FPC.0b013e328011aaff. View

Hughes W . Use of dapsone in the prevention and treatment of Pneumocystis carinii pneumonia: a review. Clin Infect Dis. 1998; 27(1):191-204. DOI: 10.1086/514626. View

Fitzsimmons S, Workman P, Grever M, Paull K, Camalier R, Lewis A . Reductase enzyme expression across the National Cancer Institute Tumor cell line panel: correlation with sensitivity to mitomycin C and EO9. J Natl Cancer Inst. 1996; 88(5):259-69. DOI: 10.1093/jnci/88.5.259. View

Huang N, Dardis A, Miller W . Regulation of cytochrome b5 gene transcription by Sp3, GATA-6, and steroidogenic factor 1 in human adrenal NCI-H295A cells. Mol Endocrinol. 2005; 19(8):2020-34. DOI: 10.1210/me.2004-0411. View

Winter H, Wang Y, Unadkat J . CYP2C8/9 mediate dapsone N-hydroxylation at clinical concentrations of dapsone. Drug Metab Dispos. 2000; 28(8):865-8. View

Rodriguez M, Fishman J . Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients. Clin Microbiol Rev. 2004; 17(4):770-82, table of contents. PMC: 523555. DOI: 10.1128/CMR.17.4.770-782.2004. View

10.

Naik P, Marshall Lyon 3rd G, Ramirez A, Lawrence E, Neujahr D, Force S . Dapsone-induced hemolytic anemia in lung allograft recipients. J Heart Lung Transplant. 2008; 27(11):1198-202. DOI: 10.1016/j.healun.2008.07.025. View

11.

Fretland A, Leff M, Doll M, Hein D . Functional characterization of human N-acetyltransferase 2 (NAT2) single nucleotide polymorphisms. Pharmacogenetics. 2001; 11(3):207-15. DOI: 10.1097/00008571-200104000-00004. View

12.

Sim S, Risinger C, Dahl M, Aklillu E, Christensen M, Bertilsson L . A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants. Clin Pharmacol Ther. 2006; 79(1):103-13. DOI: 10.1016/j.clpt.2005.10.002. View

13.

Talarico J, Metro D . Presentation of dapsone-induced methemoglobinemia in a patient status post small bowel transplant. J Clin Anesth. 2005; 17(7):568-70. DOI: 10.1016/j.jclinane.2004.10.011. View

14.

Bustin S, Benes V, Garson J, Hellemans J, Huggett J, Kubista M . The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009; 55(4):611-22. DOI: 10.1373/clinchem.2008.112797. View

15.

Kita T, Tanigawara Y, Chikazawa S, Hatanaka H, Sakaeda T, Komada F . N-Acetyltransferase2 genotype correlated with isoniazid acetylation in Japanese tuberculous patients. Biol Pharm Bull. 2001; 24(5):544-9. DOI: 10.1248/bpb.24.544. View

16.

Reilly T, Woster P, Svensson C . Methemoglobin formation by hydroxylamine metabolites of sulfamethoxazole and dapsone: implications for differences in adverse drug reactions. J Pharmacol Exp Ther. 1999; 288(3):951-9. View

17.

Kurian J, Bajad S, Miller J, Chin N, Trepanier L . NADH cytochrome b5 reductase and cytochrome b5 catalyze the microsomal reduction of xenobiotic hydroxylamines and amidoximes in humans. J Pharmacol Exp Ther. 2004; 311(3):1171-8. DOI: 10.1124/jpet.104.072389. View

18.

Naranjo C, Busto U, Sellers E, Sandor P, Ruiz I, Roberts E . A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30(2):239-45. DOI: 10.1038/clpt.1981.154. View

19.

Chen M, Xia B, Chen B, Guo Q, Li J, Ye M . N-acetyltransferase 2 slow acetylator genotype associated with adverse effects of sulphasalazine in the treatment of inflammatory bowel disease. Can J Gastroenterol. 2007; 21(3):155-8. PMC: 2657682. DOI: 10.1155/2007/976804. View

20.

Jorde U, Horowitz H, Wormser G . Utility of dapsone for prophylaxis of Pneumocystis carinii pneumonia in trimethoprim-sulfamethoxazole-intolerant, HIV-infected individuals. AIDS. 1993; 7(3):355-9. DOI: 10.1097/00002030-199303000-00008. View